[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA42810A - Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue - Google Patents

Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue

Info

Publication number
MA42810A
MA42810A MA042810A MA42810A MA42810A MA 42810 A MA42810 A MA 42810A MA 042810 A MA042810 A MA 042810A MA 42810 A MA42810 A MA 42810A MA 42810 A MA42810 A MA 42810A
Authority
MA
Morocco
Prior art keywords
monosubstituted
dengue virus
virus replication
indole derivatives
derivatives used
Prior art date
Application number
MA042810A
Other languages
English (en)
Inventor
Dorothée Alice Marie-Eve Bardiot
Jean-François Bonfanti
Tim Hugo Maria Jonckers
Bart Rudolf Romanie Kesteleyn
Arnaud Didier M Marchand
Pierre Jean-Marie Bernard Raboisson
Original Assignee
Janssen Pharmaceuticals Inc
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc, Univ Leuven Kath filed Critical Janssen Pharmaceuticals Inc
Publication of MA42810A publication Critical patent/MA42810A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA042810A 2015-09-16 2016-09-15 Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue MA42810A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15185523 2015-09-16
EP16163472 2016-04-01

Publications (1)

Publication Number Publication Date
MA42810A true MA42810A (fr) 2018-07-25

Family

ID=56926217

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042810A MA42810A (fr) 2015-09-16 2016-09-15 Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue

Country Status (30)

Country Link
US (1) US10765662B2 (fr)
EP (1) EP3350162B1 (fr)
JP (2) JP7050666B2 (fr)
KR (1) KR102646174B1 (fr)
CN (1) CN108473422B (fr)
AU (1) AU2016324982B2 (fr)
CA (1) CA2996979C (fr)
CL (1) CL2018000696A1 (fr)
CO (1) CO2018003471A2 (fr)
CR (1) CR20180213A (fr)
DK (1) DK3350162T3 (fr)
EA (1) EA035663B1 (fr)
EC (1) ECSP18020055A (fr)
ES (1) ES2893298T3 (fr)
HK (1) HK1257842A1 (fr)
HR (1) HRP20211352T1 (fr)
HU (1) HUE055870T2 (fr)
IL (1) IL258043B (fr)
JO (1) JOP20160198B1 (fr)
LT (1) LT3350162T (fr)
MA (1) MA42810A (fr)
MX (1) MX2018003255A (fr)
NI (1) NI201800039A (fr)
PE (1) PE20181165A1 (fr)
PH (1) PH12018500576A1 (fr)
SI (1) SI3350162T1 (fr)
TW (1) TWI758255B (fr)
UA (1) UA122973C2 (fr)
UY (1) UY36903A (fr)
WO (1) WO2017046255A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201116559D0 (en) 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
GB201305376D0 (en) 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
KR20210018530A (ko) 2015-12-16 2021-02-17 록쏘 온콜로지, 인코포레이티드 키나제 억제제로서 유용한 화합물
LT3436435T (lt) 2016-03-31 2021-08-25 Janssen Pharmaceuticals, Inc. Pakeistieji indolo dariniai kaip dangės viruso replikacijos inhibitoriai
EA201892216A1 (ru) 2016-03-31 2019-03-29 Янссен Фармасьютикалз, Инк. Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
EP3436004A1 (fr) * 2016-04-01 2019-02-06 Janssen Pharmaceuticals, Inc. Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
JOP20170069B1 (ar) 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) * 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
WO2018215315A1 (fr) 2017-05-22 2018-11-29 Janssen Pharmaceuticals, Inc. Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
LT3630724T (lt) * 2017-05-22 2021-08-25 Janssen Pharmaceuticals, Inc. Pakeistieji indolino dariniai, kaip dengės viruso replikacijos inhibitoriai

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177426B1 (en) * 1997-10-27 2001-01-23 Eli Lilly And Company Morpholino-N-ethyl ester prodrugs of indole sPLA2 inhibitors
GB0110832D0 (en) 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
WO2003050295A2 (fr) 2001-12-12 2003-06-19 Conforma Therapeutics Corporation Essais et mises en oeuvre permettant de determiner et de moduler une activite de liaison hsp90
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
MX2007008587A (es) 2005-01-14 2007-09-07 Genelabs Tech Inc Derivados de indol para tratamiento de infecciones virales.
MX2007009561A (es) 2005-02-09 2008-01-14 Migenix Inc Composiciones y metodos para tratar o evitar infecciones de flaviviridae.
WO2008119741A2 (fr) * 2007-03-29 2008-10-09 Novartis Ag 3-imidazolyl-indoles pour le traitement de maladies prolifératives
FR2928645A1 (fr) * 2008-03-14 2009-09-18 Sanofi Aventis Sa Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
JP2011522054A (ja) 2008-06-03 2011-07-28 シガ・テクノロジーズ・インコーポレーテッド デングウイルス感染の処置または予防のための小分子インヒビター
PE20110368A1 (es) * 2008-08-18 2011-06-13 Univ Yale Moduladores de mif
WO2010021878A1 (fr) 2008-08-19 2010-02-25 Janssen Pharmaceutica Nv Antagonistes des récepteurs au froid activés par le menthol
TWI453207B (zh) 2008-09-08 2014-09-21 Signal Pharm Llc 胺基三唑并吡啶，其組合物及使用其之治療方法
GB0910003D0 (en) 2009-06-11 2009-07-22 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
US8993604B2 (en) 2009-06-30 2015-03-31 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
WO2011088303A1 (fr) 2010-01-15 2011-07-21 Gilead Sciences , Inc. Inhibiteurs de flavivirus
US20130023532A1 (en) * 2010-03-26 2013-01-24 Casillas Linda N Indazolyl-pyrimidines as kinase inhibitors
GB201116559D0 (en) * 2011-09-26 2011-11-09 Univ Leuven Kath Novel viral replication inhibitors
GB201305376D0 (en) 2013-03-25 2013-05-08 Univ Leuven Kath Novel viral replication inhibitors
US9567299B2 (en) 2013-10-23 2017-02-14 Janssen Sciences Ireland Uc Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
KR102413453B1 (ko) 2014-01-31 2022-06-28 브리스톨-마이어스 스큅 컴퍼니 인자 XIa 억제제로서의 헤테로시클릭 P2' 기를 갖는 마크로사이클
NO2721243T3 (fr) 2014-10-01 2018-10-20
PL3201177T3 (pl) * 2014-10-01 2019-05-31 Janssen Pharmaceuticals Inc Mono- lub di-podstawione indole jako inhibitory replikacji wirusa dengi
HUE041888T2 (hu) 2014-10-01 2019-06-28 Janssen Pharmaceuticals Inc Mono- vagy diszubsztituált indol-származékok mind dengue vírus replikáció inhibitorok
JOP20150335B1 (ar) 2015-01-16 2022-03-14 Janssen Pharmaceuticals Inc مشتقات اندول بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
AR103680A1 (es) 2015-02-23 2017-05-24 Lilly Co Eli Inhibidores selectivos de bace1
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JO3633B1 (ar) 2015-09-16 2020-08-27 Katholieke Univ Leuven Ku Leuven Research & Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
BR112018009010B1 (pt) 2015-11-03 2023-09-26 Zoetis Services Llc Uso de um compósito polimérico de sol-gel para prevenir ou tratar mastite em um mamífero não humano fêmea que tem um período de lactação e sistema para formar uma barreira física no canal ou cisterna da teta do dito mamífero
US10323026B2 (en) 2016-03-31 2019-06-18 Takeda Pharmaceutical Company Limited Heterocyclic compound
LT3436435T (lt) 2016-03-31 2021-08-25 Janssen Pharmaceuticals, Inc. Pakeistieji indolo dariniai kaip dangės viruso replikacijos inhibitoriai
EA201892216A1 (ru) 2016-03-31 2019-03-29 Янссен Фармасьютикалз, Инк. Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
CR20180480A (es) 2016-04-01 2019-04-02 Amgen Inc Receptores quiméricos y métodos de uso de los mismos
EP3436004A1 (fr) 2016-04-01 2019-02-06 Janssen Pharmaceuticals, Inc. Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
KR102411744B1 (ko) 2016-04-01 2022-06-21 바스프 에스이 바이시클릭 화합물
PT3436079T (pt) 2016-04-01 2021-10-06 Kite Pharma Inc Recetores de antigénios quiméricos e de células t e métodos de uso
NZ746554A (en) 2016-04-01 2023-03-31 Signal Pharm Llc Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
JP2019516352A (ja) 2016-04-01 2019-06-20 アムジエン・インコーポレーテツド Ｆｌｔ３に対するキメラ受容体及びその使用方法
JOP20170069B1 (ar) 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180026A1 (ar) 2017-03-31 2019-01-30 Univ Leuven Kath مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20180025B1 (ar) 2017-03-31 2021-08-17 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
LT3630724T (lt) 2017-05-22 2021-08-25 Janssen Pharmaceuticals, Inc. Pakeistieji indolino dariniai, kaip dengės viruso replikacijos inhibitoriai
WO2018215315A1 (fr) 2017-05-22 2018-11-29 Janssen Pharmaceuticals, Inc. Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue

Also Published As

Publication number Publication date
WO2017046255A1 (fr) 2017-03-23
CL2018000696A1 (es) 2018-07-06
EP3350162A1 (fr) 2018-07-25
KR20180052672A (ko) 2018-05-18
HUE055870T2 (hu) 2021-12-28
UA122973C2 (uk) 2021-01-27
US20180256545A1 (en) 2018-09-13
AU2016324982B2 (en) 2021-04-15
EP3350162B1 (fr) 2021-07-14
DK3350162T3 (da) 2021-10-04
EA035663B1 (ru) 2020-07-23
PH12018500576A1 (en) 2018-10-15
LT3350162T (lt) 2021-09-27
JOP20160198B1 (ar) 2022-03-14
IL258043B (en) 2021-08-31
JP2021181485A (ja) 2021-11-25
EA201890722A1 (ru) 2018-09-28
UY36903A (es) 2017-03-31
SI3350162T1 (sl) 2021-11-30
JP2018528220A (ja) 2018-09-27
TW201722913A (zh) 2017-07-01
HRP20211352T1 (hr) 2022-02-04
NI201800039A (es) 2018-07-24
PE20181165A1 (es) 2018-07-19
US10765662B2 (en) 2020-09-08
IL258043A (en) 2018-05-31
MX2018003255A (es) 2018-11-09
TWI758255B (zh) 2022-03-21
CA2996979C (fr) 2024-01-30
ECSP18020055A (es) 2018-04-30
KR102646174B1 (ko) 2024-03-08
CN108473422B (zh) 2021-06-15
JP7050666B2 (ja) 2022-04-08
AU2016324982A1 (en) 2018-03-15
CN108473422A (zh) 2018-08-31
ES2893298T3 (es) 2022-02-08
CA2996979A1 (fr) 2017-03-23
CO2018003471A2 (es) 2018-07-10
HK1257842A1 (zh) 2019-11-01
CR20180213A (es) 2018-06-27

Similar Documents

Publication Publication Date Title
MA42810A (fr) Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue
MA44498A (fr) Dérivés d'indoline substituée utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue
MA44502A (fr) Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
MA41341A (fr) Dérivés indole utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue
MA48987A (fr) Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
MA48943A (fr) Dérivés d'indoline substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
MA47125A (fr) Dérivés de pyrazole en tant qu'inhibiteurs de malt1
MA47123A (fr) Dérivés de benzooxazole en tant qu'mmunomodulateurs
MA45244A (fr) Pyridines substituées utilisées en tant qu'inhibiteurs de dnmt1
MA48994A (fr) Isoquinoléines utilisées en tant qu'inhibiteurs de hpk1
MA41140A (fr) Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
DK3328843T3 (da) 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning
MA46339A (fr) Dérivés de cyanopyrrolidine ayant une activité en tant qu'inhibiteurs de l'usp 30
MA47120A (fr) Dérivés pyridine utilisés en tant qu'immunomodulateurs
MA47460A (fr) Aminotriazolopyridines utilisées en tant qu'inhibiteurs de kinase
MA46981A (fr) Dérivés de benzimidazole en tant qu'inhibiteurs de bromodomaine
MA42659A (fr) Dérivés hétéroaryle utilisés en tant qu'inhibiteurs de parp
MA40774A (fr) Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
DK3362445T3 (da) Oxadiazolaminderivatforbindelser som histondeacetylase 6-inhibitor, og den farmaceutiske sammensætning dermed
DK3302448T3 (da) Erstattede heterocyclylafledninger som cdk-inhibitore
MA40943A (fr) Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
DK3294738T3 (da) Mono- og disubstituerede indolderivater som inhibitorer af replikation af denguevirus
MA40940A (fr) Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
MA47086A (fr) Dérivés de dihydropyrimidine-carboxamide bicycliques utilisés en tant qu'inhibiteurs de rho-kinase
DK3350163T3 (da) Mono- eller disubstituerede indolderivater som hæmmere af denguevirusreplikation